# Colistin Dosage Prsonalization Approach

> **NCT06472271** · — · RECRUITING · sponsor: **Mahmoud I Mostafa** · enrollment: 100 (estimated)

## Conditions studied

- Colistin Adverse Reaction

## Interventions

- **DRUG:** Polymyxin e

## Key facts

- **NCT ID:** NCT06472271
- **Lead sponsor:** Mahmoud I Mostafa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2024-11-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472271, "Colistin Dosage Prsonalization Approach". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06472271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*